Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 81 of 81 entries
View as:

Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE)

Phase: N/A Priority: Normal
NCT ID: NCT02000050 Org: User:
Start: 10/11/13 End: 03/15/19 Due: 03/15/20

Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01885013 Org: User:
Start: 09/30/10 End: 05/31/15 Due: 05/31/16

What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer?

Phase: N/A Priority: Normal
NCT ID: NCT04590560 Org: User:
Start: 02/06/20 End: 02/28/26 Due: 02/28/27

The Role of Early Systematic Best Palliative Care Versus on Request Palliative Care Consultation During Standard Oncologic Treatment for Patients With Advanced Gastric or Pancreatic Cancers: a Randomized, Controlled, Multicenter Trial.

Phase: N/A Priority: Normal
NCT ID: NCT01996540 Org: User:
Start: 08/31/12 End: 11/30/18 Due: 11/30/19

Gemcitabine in Combination With Pemetrexed Long Term Infusion in the Treatment of Pretreated Metastatic Colorectal Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01909830 Org: User:
Start: 07/31/12 End: 03/31/14 Due: 03/31/15

Pre-Operative Or Peri-Operative Dox Regimen In Patients With Locally Advanced Resectable Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01876927 Org: User:
Start: 09/30/10 End: 09/15/22 Due: 09/15/23